Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
19.37
+0.40 (2.11%)
Jun 24, 2026, 3:22 PM EDT - Market open
Seaport Therapeutics Earnings Call Transcripts
Fiscal Year 2026
-
The company presented its neuropsychiatry-focused pipeline, highlighting the Glyph platform's ability to improve oral bioavailability and safety of known drugs. Key milestones include phase II-B and driving study data for GlyphAllo in 2026–2027 and phase II studies for GlyphAgo in 2028, with funding secured into 2029.